Radiant InsightsRadiantInsights.com include new market research report “Dyslipidemia, Dengue And Dementia Pipeline Market Review Up To 2015” to its huge collection of research reports.Dyslipidemia – Pipeline Review, H1 2015
Summary
Global Markets Direct’s, ‘Dyslipidemia – Pipeline Review, H1 2015′, provides an overview of the Dyslipidemia’s therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Dyslipidemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Dyslipidemia and special features on late-stage and discontinued projects.
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
For more Information About Dyslipidemia – Pipeline Review, H1 2015 Click:
http://www.radiantinsights.com/research/dyslipidemia-pipeline-review-h1-2015
Dengue – Pipeline Review, H1 2015
Summary
Global Markets Direct’s, ‘Dengue – Pipeline Review, H1 2015′, provides an overview of the Dengue’s therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Dengue, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Dengue and special features on late-stage and discontinued projects.
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
For more Information About Dengue – Pipeline Review, H1 2015 Click:
http://www.radiantinsights.com/research/dengue-pipeline-review-h1-2015
Dementia – Pipeline Review, H1 2015
Summary
Global Markets Direct’s, ‘Dementia – Pipeline Review, H1 2015′, provides an overview of the Dementia’s therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Dementia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Dementia and special features on late-stage and discontinued projects.
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
For more Information About Dementia – Pipeline Review, H1 2015 Click:
http://www.radiantinsights.com/research/dementia-pipeline-review-h1-2015
About Radiant Insights
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
For more information, visit: http://www.radiantinsights.com/
Blog URL: http://www.terrapass.org/
Media Contact
Company Name: PTA Newsroom
Contact Person: Michelle Thoras
Email: Send Email
Phone: 1-800-489-3075
Address:Felton Office Plaza, 6265 Highway 9
City: Felton
State: California
Country: United States
Website: http://www.radiantinsights.com/research/dyslipidemia-pipeline-review-h1-2015
Source: www.abnewswire.com
